Hossam El Benawi on Impact of Timing of Atrial Fibrillation Ablation
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn:
”’Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF”:
Using TriNetX (2010–2024), we studied HF patients with AF (after HF onset)undergoing early (≤1 yr) vs delayed (1–3 yrs) ablation, (7654 HFrEF, 3033 HFpEF ):
- Delayed ablation was linked to higher AF recurrence in both HFpEF and HFrEF.
- In HFrEF, delayed ablation →
↑ Redo ablation, ↑ DCCV , ↑ AAD use - HFpEF, delayed ablation →
Redo ablation and DCCV, but↑ AAD use - No significant differences in:
Stroke, HF hospitalizations, All-cause hospitalizations, Mortality between early vs delayed ablation in both groups.
Study link.”
Read the full article here.
Article: Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF
Authors: Mahmoud Eisa, Hossam Elbenawi, Momina Iftikhar, Ahmed El Shaer, Muhammad Eltony, Omar Almaadawy, Amro Aglan, Mahmoud Samy Ahmed, Kareem A. Mohamed, Khaled Elfert, Mahmoud Shadi, Mohan Rao, Justin Z. Lee, Zain Ul Abideen Asad, Freddy Del-Carpio Munoz, Konstantinos C. Siontis, Mark S. Link, Abhishek J. Deshmukh, Christopher V. DeSimone

Stay updated on all scientific advances with Hemostasis Today.
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications
-
Jan 6, 2026, 09:52Antoine Francis: Plasma is Not Just Another Component of Healthcare…
-
Jan 6, 2026, 09:45Hurry to Join EHC Youth Leadership Workshop 2026
-
Jan 6, 2026, 09:41Andrew Petrosoniak Makes It to N1 on EMCases Best of 2025!
-
Jan 6, 2026, 09:35Sara Ng: Moving Beyond Management to Stewardship – “Advancing Anticoagulation Stewardship” Released by NQF
-
Jan 6, 2026, 09:30Wolfgang Miesbach: Excellent 4-Year Data of Etranacogene Dezaparvovec in Haemophilia B
-
Jan 6, 2026, 09:09Abdulrahman Nasiri: A New Perspective on Avatrombopag in Aplastic Anemia
